{"news_desk": "National", "print_page": "16", "section_name": "U.S.", "subsection_name": null, "byline": {"contributor": "", "original": "By THE ASSOCIATED PRESS", "person": [], "organization": "THE ASSOCIATED PRESS"}, "abstract": "New type of blood test, called liquid biopsy, may transform tumor cell monitoring by capturing cancer cells that tumors shed into blood, instead of taking tissue from tumor itself.", "type_of_material": "Brief", "word_count": "90", "lead_paragraph": "The tests, called liquid biopsies, capture cancer cells or DNA that tumors shed into the blood, instead of taking tissue from the tumor itself.", "pub_date": "2015-05-12T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "New Test Could Spare Patients From Biopsies ", "content_kicker": "National Briefing | Science", "print_headline": "New Test Could Spare Patients From Biopsies "}, "snippet": "The tests, called liquid biopsies, capture cancer cells or DNA that tumors shed into the blood, instead of taking tissue from the tumor itself.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/05/12/us/new-test-could-spare-patients-from-biopsies.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Cancer", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Tests (Medical)", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "DNA (Deoxyribonucleic Acid)", "name": "subject"}], "blog": [], "_id": "5551649638f0d84851b12d3c", "source": "The New York Times"}